Lantern Pharma Inc. (LTRN)
Nasdaq: LTRN · Pharmaceutical Preparations · Dallas, TX · filing with the SEC since 2019
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| Report filed | Mar 30, 2026 | Mar 27, 2025 | Mar 18, 2024 | Mar 20, 2023 | Mar 10, 2022 | Mar 10, 2021 | · |
| Research and development | 11,514,123 | 16,125,690 | 11,894,315 | 8,602,954 | 7,570,580 | 2,243,225r | · |
| General and administrative | 6,464,371 | 6,090,747 | 5,983,255 | 5,829,799 | 5,020,928 | 3,664,965 | 1,475,000 |
| Total operating expenses | 17,978,494 | 22,216,437 | 17,877,570 | 14,432,753 | 12,591,508 | 5,908,190 | 2,428,185 |
| Total costs and expenses | · | · | · | · | 12,591,508 | 5,908,190 | · |
| Operating income | -17,978,494 | -22,216,437 | -17,877,570 | -14,432,753 | -12,591,508 | · | · |
| Interest and investment income | 437,931 | 742,355 | 765,388 | 204,355 | 67,929 | · | · |
| Other income (expense), net | 421,125 | 692,869 | 1,150,648 | -31,548 | 160,550 | · | · |
| Net income including non-controlling interests | · | · | · | · | -12,363,029 | -5,908,190r | 2,428,000 |
| Net income to non-controlling interests | · | · | · | · | 12,363,000 | 5,908,000 | · |
| Net income | -17,119,438 | -20,781,213 | -15,961,534 | -14,259,946 | -12,363,029 | -5,908,190 | -2,428,185 |
| Net income to common shareholders | · | · | · | · | -12,363,029 | -5,908,190 | · |
| Earnings per share, basic | -1.57 | -1.93 | -1.47 | -1.31 | -1.13 | · | · |
| Earnings per share, diluted | -1.57 | -1.93 | -1.47 | -1.31 | · | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -1.13 | -1.37 | -1.23 |
| Weighted average shares, basic | 10,898,175 | 10,762,319 | 10,842,365 | 10,850,579 | 10,904,927 | · | · |
| Weighted average shares, diluted | 10,898,175 | 10,762,319 | 10,842,365 | 10,850,579 | · | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 10,904,927 | 4,304,918 | 1,978,269 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:OperatingCostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InterestIncomeOtherOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted